{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T12:28:44Z","timestamp":1786796924693,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.radonc.2026.111641","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:58:44Z","timestamp":1781312324000},"page":"111641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Outcomes of two or more rounds of hematopoietic stem cell transplantation using total body irradiation for hematological malignancies"],"prefix":"10.1016","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5439-172X","authenticated-orcid":false,"given":"Keiko Nemoto","family":"Murofushi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8910-0021","authenticated-orcid":false,"given":"Yuho","family":"Najima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8360-5544","authenticated-orcid":false,"given":"Satoshi","family":"Kito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Ogoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5792-3795","authenticated-orcid":false,"given":"Kei","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9763-0743","authenticated-orcid":false,"given":"Takuya","family":"Shimizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Toya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-3179","authenticated-orcid":false,"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111641_b0005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MOH.0b013e3283257a87","article-title":"Second hematopoietic stem cell transplantation in myeloid malignancies","volume":"16","author":"Arfons","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.radonc.2026.111641_b0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2013.08.012","volume":"20","author":"de Lima","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2026.111641_b0015","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1182\/bloodadvances.2025018139","article-title":"No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse","volume":"10","author":"Murdock","year":"2026","journal-title":"Blood Adv"},{"key":"10.1016\/j.radonc.2026.111641_b0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/ejh.13947","article-title":"Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation","volume":"110","author":"Ferra Coll","year":"2023","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.radonc.2026.111641_b0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jcyt.2024.09.006","article-title":"Outcome of donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation in relapsed myelodysplastic syndrome","volume":"27","author":"Marumo","year":"2025","journal-title":"Cytotherapy"},{"key":"10.1016\/j.radonc.2026.111641_b0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41408-024-01060-4","article-title":"Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients","volume":"14","author":"Schm\u00e4lter","year":"2024","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.radonc.2026.111641_b0035","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00277-020-04089-0","article-title":"Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation","volume":"99","author":"Kaito","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.radonc.2026.111641_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1066748","article-title":"Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: a single center study","volume":"13","author":"Lu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2026.111641_b0045","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14199","article-title":"Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation","volume":"35","author":"Choi","year":"2021","journal-title":"Clin Transplant"},{"key":"10.1016\/j.radonc.2026.111641_b0050","first-page":"01635","article-title":"Novel scoring system using geriatric nutritional risk index, C-reactive protein, and disease status predicts survival after second allogeneic stem cell transplantation","volume":"S2666\u20136367","author":"Sadaga","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.radonc.2026.111641_b0055","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jtct.2023.04.014","article-title":"Total marrow irradiation for second allogeneic hematopoietic stem cell transplantation in patients wiht advanced acute leukemia","volume":"29","author":"Dominietto","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.radonc.2026.111641_b0060","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/jrr\/rraa078","article-title":"Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic stem cell transplantation: a prospective pilot study","volume":"61","author":"Konishi","year":"2020","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2026.111641_b0065","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1259\/0007-1285-58-690-515","article-title":"The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy","volume":"58","author":"Dale","year":"1985","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2026.111641_b0070","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2026.111641_b0075","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2026.111641_b0080","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2026.111641_b0085","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111641_b0090","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2026.111641_b0095","article-title":"Total marrow irradiation in hematopoietic stem cell transplantation for hematologic malignancies","volume":"10","author":"Kerbauy","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.radonc.2026.111641_b0100","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1080\/07853890.2022.2125171","article-title":"Outcomes of allogeneic haematopoietic stem cell transplantation with intensity-modulated total body irradiation by helical tomotherapy: a 2-year prospective follow-up study","volume":"54","author":"Konishi","year":"2022","journal-title":"Ann Med"},{"key":"10.1016\/j.radonc.2026.111641_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1044539","article-title":"Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapy","volume":"12","author":"Ladbury","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111641_b0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1532\/IJH97.05046","article-title":"Influence of radiation dose rate and lung dose on interstitial pneumonitis after fractionated total body irradiation: acute parotitis may predict interstitial pneumonitis","volume":"83","author":"Oya","year":"2006","journal-title":"Int J Hematol"},{"key":"10.1016\/j.radonc.2026.111641_b0115","first-page":"361","article-title":"Comparison between single-dose and hyperfractionated total-body irradiation for the conditioning of allogeic graft of the bone marrow. a retrospective study of 54 patents with makignant hematologic disease","volume":"75","author":"Baume","year":"1988","journal-title":"Bull Cancer"},{"key":"10.1016\/j.radonc.2026.111641_b0120","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0360-3016(02)03039-0","article-title":"Renal toxicity after total body irradiation","volume":"54","author":"Borg","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111641_b0125","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ijrobp.2006.02.021","article-title":"Renal dysfunction after total body irradiation: dose-effect relationship","volume":"65","author":"Kal","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111641_b0130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0360-3016(89)90446-X","article-title":"Technical modifications in hyperfractionated total body irradiation for T-lymphocyte deplete bone marrow transplant","volume":"17","author":"Lawton","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111641_b0135","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0360-3016(92)90909-2","article-title":"Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide - a phase I trial","volume":"23","author":"Petersen","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111641_b0140","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0360-3016(95)00115-F","article-title":"Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a phase I\/II trial","volume":"32","author":"Demirer","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111641_b0145","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1200\/JCO.2000.18.5.981","article-title":"Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies","volume":"18","author":"Girinsky","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111641_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1459287","article-title":"Volumetric modulated arc therapy total body irradiation improves toxicity outcomes compared to 2D total body irradiation","volume":"14","author":"Hui","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111641_b0155","first-page":"507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Ogonek","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2026.111641_b0160","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/ejh.70085","article-title":"Factors affecting immune reconstition post-allogeneic HSCT in children: the case for an individualized approarch to vaccination","volume":"116","author":"Buvelot","year":"2026","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.radonc.2026.111641_b0165","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1016\/S2352-3026(21)00274-X","article-title":"Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT","volume":"8","author":"Redjoul","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.radonc.2026.111641_b0170","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ajh.22009","article-title":"Incidence, risk factors, and clinical outcomes of cataracts following hematopoietic stem cell transplantation","volume":"86","author":"Najima","year":"2011","journal-title":"Am J Hematol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026004809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026004809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T12:19:42Z","timestamp":1786796382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026004809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S0167814026004809"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111641","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of two or more rounds of hematopoietic stem cell transplantation using total body irradiation for hematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111641","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111641"}}